An update on the role of the 5-hydroxytryptamine6 receptor in cognitive function

Neuropharmacology

Volumn 55, Issue 6, 2008, Pages 1015-1022

  Fone, Kevin C F ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

5 Hyroxytryptamine6 receptor; Cognition; learning and memory; Morris water maze; Novel object discrimination; Serotonin

Indexed keywords

2 CHLORO N [3 [(1 METHYL 2 PYRROLIDINYL)METHYL] 1H INDOL 5YL]BENZENESULFONAMIDE; 4 AMINO N [2,6 BIS(METHYLAMINO) 4 PYRIMIDINYL]BENZENESULFONAMIDE; 5 CHLORO N [4 METHOXY 3 (1 PIPERAZINYL)PHENYL] 3 METHYL 2 BENZOTHIOPHENESULFONAMIDE; BENZENESULFONAMIDE DERIVATIVE; BGC 20761; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHENCYCLIDINE; PRX 07034; RO 4368554; SB 357134; SB 399885; SCOPOLAMINE; SEROTONIN 6 AGONIST; SEROTONIN 6 ANTAGONIST; SEROTONIN 6 RECEPTOR; SEROTONIN AGONIST; UNCLASSIFIED DRUG; WAY 181187;

ARTICLE; CHOLINERGIC TRANSMISSION; COGNITION; HUMAN; LEARNING; MAZE TEST; MEMORY; MEMORY CONSOLIDATION; NONHUMAN; PRIORITY JOURNAL; RECOGNITION; RODENT; SOCIAL ISOLATION; SPATIAL MEMORY;

ANIMALS; COGNITION; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; HUMANS; MENTAL DISORDERS; RATS; RECEPTORS, SEROTONIN; SEROTONIN AGENTS;

EID: 53449090731     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2008.06.061     Document Type: Article

References (86)

1. Bentley J., Sleight A.J., Marsden C.A., and Fone K.C.F. 5-HT6 antisense oligonucleotide i.c.v. affects rat performance in the water maze and feeding. Journal of Psychopharmacology 11 (1997) A64
2. Bentley J.C., Bourson A., Boess F.G., Fone K.C.F., Marsden C.A., Petit N., and Sleight A.J. Investigation of stretching behaviour induced by the selective 5-HT6 receptor antagonist, Ro 04-6790, in rats. British Journal of Pharmacology 126 (1999) 1537-1542
3. Beyer C.E., Smith D.L., Zhang G., Li P., Lin Q., Stock J.R., Ellingboe J.W., Bernotas R., Cole D.C., Dawson L.A., and Schechter L.E. WAY-181187: neurochemical profile of a novel and selective 5-HT6 receptor agonist. European Neuropsychopharmacology 15 (2005) S382
4. Birrell J.M., and Brown V.J. Medial frontal cortex mediates perceptual attentional set shifting in the rat. Journal of Neuroscience 20 (2000) 4320-4324
5. Bonasera S.J., Chu H.M., Brennan T.J., and Tecott L.H. A null mutation of the serotonin 6 receptor alters acute responses to ethanol. Neuropsychopharmacology 31 (2006) 1801-1813
6. Bonsi P., Cuomo D., Ding J., Sciamanna G., Ulrich S., Tscherter A., Bernardi G., Surmeier D.J., and Pisani A. Endogenous serotonin excites striatal cholinergic interneurons via the activation of 5-HT 2C, 5-HT6, and 5-HT7 serotonin receptors: implications for extrapyramidal side effects of serotonin reuptake inhibitors. Neuropsychopharmacology 32 (2007) 1840-1854
7. Bos M., Sleight A.J., Godel T., Martin J.R., Riemer C., and Stadler H. 5-HT6 receptor antagonists: lead optimisation and biological evaluation of N-aryl and N-heteroaryl 4-amino-benzene sulfonamides. European Journal of Medicinal Chemistry 36 (2001) 165-178
8. Branchek T.A., and Blackburn T.P. 5-HT6 receptors as emerging targets for drug discovery. Annual Review of Pharmacology and Toxicology 40 (2000) 319-334
9. Burnham, K.E., Baxter, M.G., Bainton, J., Southam, E., Dawson, L.A., Sharp, T., Bannerman, D.M., 2007. The 5-HT6 receptor agonist WAY181187 enhances extra-dimensional set-shifting in the rat. British Journal of Pharmacology pA2online.org/abstracts/Vol5Issue2abst027P.
10. Cole D.C., Lennox W.J., Lombardi S., Ellingboe J.W., Bernotas R.C., Tawa G.J., Mazandarani H., Smith D.L., Zhang G.M., Coupet J., and Schechter L.E. Discovery of 5-arylsulfonamido-3(pyrrolidin-2-ylmethyl)-1H-indole derivatives as potent, selective 5-HT6 receptor agonists and antagonists. Journal of Medicinal Chemistry 48 (2005) 353-356
11. Dawson L.A., Nguyen H.Q., and Li P. The 5-HT6 receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus. Neuropsychopharmacology 25 (2001) 662-668
12. De Foubert G., O'Neill M.J., and Zetterstrom T.S.C. Acute onset by 5-HT6-receptor activation on rat brain brain-derived neurotrophic factor and activity-regulated cytoskeletal-associated protein mRNA expression. Neuroscience 147 (2007) 778-785
13. Fisas A., Codony X., Romero G., Dordal A., Giraldo J., Merce R., Holenz J., Heal D., Buschmann H., and Pauwels P.J. Chronic 5-HT6 receptor modulation by E-6837 induces hypophagia and sustained weight loss in diet-induced obese rats. British Journal of Pharmacology 148 (2006) 973-983
14. Foley A.G., Murphy K.J., Hirst W.D., Gallagher H.C., Hagan J.J., Upton N., Walsh F.S., and Regan C.M. The 5-HT6 antagonists SB-271046 and SB-399885 increase basal and learning induced hippocampal ncam-polysialylation. International Journal of Neuropsychopharmacology 7 (2004) S215
15. Foley A.G., Murphy K.J., Hirst W.D., Gallagher H.C., Hagan J.J., Upton N., Walsh F.S., and Regan C.M. The 5-HT6 receptor antagonist SB-271046 reverses scopolamine-disrupted consolidation of a passive avoidance task and ameliorates spatial task deficits in aged rats. Neuropsychopharmacology 29 (2004) 93-100
16. Foley A.G., Hirst W.D., Gallagher H.C., Barry C., Hagan J.J., Upton N., Walsh F.S., Hunter A.J., and Regan C.M. The selective 5-HT(6) receptor antagonist SB-271046 and SB-399885 potentiate NCAM-PSA immunolabeling of dentate gyrus cells, but not neurogenesis, in the hippocampal formation of mature Wistar rats. Neuropharmacology 54 (2008) 1166-1174
17. Fone K.C.F., and Porkess M.V. Behavioural and neurochemical effects of post-weaning social isolation in rodents-relevance to developmental neuropsychiatric disorders. Neuroscience and Biobehavioral Reviews 32 (2008) 1087-1102
18. Gerard C., El Mestikawy S., Lebrand C., Adrien J., Ruat M., Traiffort E., Hamon M., and Martres M.P. Quantitative RT-PCR distribution of serotonin 5-HT6 receptor mRNA in the central nervous system of control or 5,7-dihydroxytryptamine-treated rats. Synapse 23 (1996) 164-173
19. Gerard C., Martres M.P., Lefevre K., Miquel M.C., Vege D., Lanfumey L., Doucet E., Hamon M., and ElMestikawy S. Immuno-localization of serotonin 5-HT6 receptor-like material in the rat central nervous system. Brain Research 746 (1997) 207-219
20. Hatcher P.D., Brown V.J., Tait D.S., Bate S., Overend P., Hagan J.J., and Jones D.N.C. 5-HT6 receptor antagonists improve performance in an attentional set shifting task in rats. Psychopharmacology 181 (2005) 253-259
21. Heal D.J., Smith S.L., Fisas A., Codony X., and Buschmann H. Selective 5-HT6 receptor ligands: Progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders. Pharmacology & Therapeutics 117 (2008) 207-231
22. Hirst W.D., Abrahamsen B., Blaney F.E., Calver A.R., Aloj L., Price G.W., and Medhurst A.D. Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling. Molecular Pharmacology 64 (2003) 1295-1308
23. Hirst W.D., Stean T.O., Rogers D.C., Sunter D., Pugh P., Moss S.F., Bromidge S.M., Riley G., Smith D.R., Bartlett S., Heidbreder C.A., Atkins A.R., Lacroix L.P., Dawson L.A., Foley A.G., Regan C.M., and Upton N. SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models. European Journal of Pharmacology 553 (2006) 109-119
24. Holenz J., Pauwels P.J., Diaz J.L., Merce R., Codony X., and Buschmann H. Medicinal chemistry strategies to 5-HT6 receptor ligands as potential cognitive enhancers and antiobesity agents. Drug Discovery Today 11 (2006) 283-299
25. Keefe R.S.E., Bilder R.M., Davis S.M., Harvey P.D., Palmer B.W., Gold J.M., Meltzer H.Y., Green M.F., Capuano G., Stroup T.S., McEvoy J.P., Swartz M.S., Roscnheck R.A., Perkins D.O., Davis C.E., Hsiao J.K., Lieberman J.A., and Neurocognitive C.I. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial. Archives of General Psychiatry 64 (2007) 633-647
26. King M.V., Sleight A.J., Woolley M.L., Topham I.A., Marsden C.A., and Fone K.C.F. 5-HT6 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing consolidation-an effect sensitive to NMDA receptor antagonism. Neuropharmacology 47 (2004) 195-204
27. King M.V., Sleight A.J., Fone K.C.F., and Marsden C.A. The selective 5-HT6 receptor antagonist Ro 04-6790 reverses age-related and chronic intermittent PCP-induced cognitive dysfunction in rats. Journal of Psychopharmacology 19 (2005) A12
28. King M.V., Sleight A.J., Fone K.C.F., and Marsden C.A. A 5-HT6 receptor agonist prolongs memory in the novel object discrimination (NOD) task. Journal of Psychopharmacology 20 (2006) A66
29. King M.V., Spicer C.H., Sleight A.J., Fone K.C.F., and Marsden C.A. Influence of median or dorsal raphe 5,7-DHT lesions on 5-HT6 receptor antagonist activity in a novel object discrimination paradigm. Journal of Pharmacological Science 101 (2006) S97
30. King M.V., Fone K.C.F., Shacham S., and Gannon K.S. The novel 5-HT6 receptor antagonist, PRX-07034, enhances memory and reduces food intake in a neurodvelopmental model of schizophrenia. Journal of Psychopharmacology 21 (2007) A57
31. Kirkpatrick B., Fenton W.S., Carpenter W.T., and Marder S.R. The NIMH-MATRICS consensus statement on negative symptoms. Schizophrenia Bulletin 32 (2006) 214-219
32. Kohen R., Metcalf M.A., Khan N., Druck T., Huebner K., Lachowicz J.E., Meltzer H.Y., Sibley D.R., Roth B.L., and Hamblin M.W. Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor. Journal of Neurochemistry 66 (1996) 47-56
33. Kohen R., Fashingbauer L.A., Heidmann D.E.A., Guthrie C.R., and Hamblin M.W. Cloning of the mouse 5-HT6 serotonin receptor and mutagenesis studies of the third cytoplasmic loop. Molecular Brain Research 90 (2001) 110-117
34. Lacroix L.P., Dawson L.A., Hagan J.J., and Heidbreder C.A. 5-HT6 receptor antagonist SB-271046 enhances extracellular levels of monoamines in the rat medial prefrontal cortex. Synapse 51 (2004) 158-164
35. Leng A., Ouagazzal A., Feldon J., and Higgins G.A. Effect of the 5-HT6 receptor antagonists Ro 04-6790 and Ro 65-7199 on latent inhibition and prepulse inhibition in the rat: comparison to clozapine. Pharmacology Biochemistry and Behavior 75 (2003) 281-288
36. Lieben C.K.J., Blokland A., Sik A., Sung E., van Nieuwenhuizen P., and Schreiber R. The selective 5-HT6 receptor antagonist Ro4368554 restores memory performance in cholinergic and serotonergic models of memory deficiency in the rat. Neuropsychopharmacology 30 (2005) 2169-2179
37. Lindner M.D., Hodges D.B., Hogan J.B., Orie A.F., Corsa J.A., Barten D.M., Polson C., Robertson B.J., Guss V.L., Gillman K.W., Starrett J.E., and Gribkoff V.K. An assessment of the effects of serotonin 6 (5-HT6) receptor antagonists in rodent models of learning. Journal of Pharmacology and Experimental Therapeutics 307 (2003) 682-691
38. Loiseau F., Dekeyne A., and Millan M.J. Pro-cognitive effects of 5-HT6 receptor antagonists in the social recognition procedure in rats: implication of the frontal cortex. Psychopharmacology 196 (2008) 93-104
39. Mann R., Lee V., Porkess M.V., King M.V., Topham I.A., Marsden C.A., and Fone K.C.F. Isolation rearing impairs recognition memory and reversal learning in the rat. Journal of Psychopharmacology 19 (2005) A39
40. Marcos B., Gil-Bea F.J., Hirst W.D., Garcia-Alloza M., and Ramirez M.J. Lack of localization of 5-HT6 receptors on cholinergic neurons: implication of multiple neurotransmitter systems in 5-HT6 receptor-mediated acetylcholine release. European Journal of Neuroscience 24 (2006) 1299-1306
41. Max S.I., Monsma F.J., and Sibley D.R. Agonist-induced desensitisation of 5-HT6 serotonin receptor-coupled adenylyl cyclase in stably transfected HEK-293 cells. Journal of Serotonin Research 2 (1995) 101-116
42. Meneses A. Effects of the 5-HT6 receptor antagonist Ro 04-6790 on learning consolidation. Behavioural Brain Research 118 (2001) 107-110
43. Meneses A., Manuel-Apolinar L., Castillo C., and Castillo E. Memory consolidation and amnesia modify 5-HT6 receptors expression in rat brain: An autoradiographic study. Behavioural Brain Research 178 (2007) 53-61
44. Millan M.J. Serotonin 5-HT2C receptors as a target for the treatment of depressive and anxious states: Focus on novel therapeutic strategies. Therapie 60 (2005) 441-460
45. Minabe Y., Shirayama Y., Hashimoto K., Routledge C., Hagan J.J., and Ashby C.R. Effect of the acute and chronic administration of the selective 5-HT6 receptor antagonist SB-271046 on the activity of midbrain dopamine neurons in rats: An in vivo electrophysiological study. Synapse 52 (2004) 20-28
46. Mitchell E.S., and Neumaier J.F. 5-HT6 receptors: a novel target for cognitive enhancement. Pharmacology & Therapeutics 108 (2005) 320-333
47. Mitchell E.S., and Neumaier J.F. 5-HT6 receptor antagonist reversal of emotional learning and prepulse inhibition deficits induced by apomorphine or scopolamine. Pharmacology Biochemistry and Behavior 88 (2008) 291-298
48. Mitchell E.S., Hoplight B.J., Lear S.P., and Neumaier J.F. BGC20-761, a novel tryptamine analog, enhances memory consolidation and reverses scopolamine-induced memory deficit in social and visuospatial memory tasks through a 5-HT6 receptor-mediated mechanism. Neuropharmacology 50 (2006) 412-420
49. Mitchell E.S., Sexton T., and Neumaier J.F. Increased expression of 5-HT6 receptors in the rat dorsomedial striatum impairs instrumental learning. Neuropsychopharmacology 32 (2007) 1520-1530
50. Monsma F.J., Shen Y., Ward R.P., Hamblin M.W., and Sibley D.R. Cloning and Expression of a Novel Serotonin Receptor with High-Affinity for Tricyclic Psychotropic-Drugs. Molecular Pharmacology 43 (1993) 320-327
51. Montgomery S.A., and van Zwieten-Boot B.J. ECNP Consensus Meeting. Negative, depressive and cognitive symptoms of schizophrenia. Nice, 2004. European Neuropsychopharmacology 17 (2007) 70-77
52. Olsen M.A., Nawoschik S.P., Schurman B.R., Schmitt H.L., Burno M., Smith D.L., and Schechter L.E. Identification of a human 5-HT6 receptor variant produced by alternative splicing. Molecular Brain Research 64 (1999) 255-263
53. Otano A., Frechilla D., Cobreros A., Cruz-Orive L.M., Insausti A., Insausti R., Hamon M., and Del Rio J. Anxiogenic-like effects and reduced stereological counting of immunolabelled 5-hydroxytryptamine(6) receptors in rat nucleus accumbens by antisense oligonucleotides. Neuroscience 92 (1999) 1001-1009
54. Pauwels P., Slotten H., Fone K., Merce R., Buschmann H., and Codony X. Memory enhancing properties of E-6801, a 5-HT6 receptor ligand with agonist properties, in the novel object discrimination test. Acta Pharmacologica Sinica 27 (2006) 76
55. Perez-Garcia G., and Meneses A. Oral administration of the 5-HT6 receptor antagonists SB-357134 and SB-399885 improves memory formation in an autoshaping learning task. Pharmacology Biochemistry and Behavior 81 (2005) 673-682
56. Pouzet B., Didriksen M., and Arnt J. Effects of the 5-HT6 receptor antagonist, SB-271046, in animal models for schizophrenia. Pharmacology Biochemistry and Behavior 71 (2002) 635-643
57. Pullagurla M., Bondareva T., Young R., and Glennon R.A. Modulation of the stimulus effects of (+)amphetamine by the 5- HT6 antagonist MS-245. Pharmacology Biochemistry and Behavior 78 (2004) 263-268
58. Riemer C., Borroni E., Levet-Trafit B., Martin J.R., Poli S., Porter R.H.P., and Bos M. Influence of the 5-HT6 receptor on acetylcholine release in the cortex: Pharmacological characterization of 4-(2-bromo-6- pyrrolidin-1-ylpyridine-4-sulfonyl)phenylamine, a potent and selective 5-HT6 receptor antagonist. Journal of Medicinal Chemistry 46 (2003) 1273-1276
59. Roberts J.C., Reavill C., East S.Z., Harrison P.J., Patel S., Routledge C., and Leslie R.A. The distribution of 5-HT6 receptors in rat brain: an autoradiographic binding study using the radiolabelled 5-HT6 receptor antagonist I-125 SB-258585. Brain Research 934 (2002) 49-57
60. Rogers D.C., and Hagan J.J. 5-HT6 receptor antagonists enhance retention of a water maze task in the rat. Psychopharmacology 158 (2001) 114-119
61. Romero G., Sanchez E., Pujol M., Perez P., Codony X., Holenz J., Buschmann H., and Pauwels P.J. Efficacy of selective 5-HT6 receptor ligands determined by monitoring 5-HT6 receptor-mediated cAMP signaling pathways. British Journal of Pharmacology 148 (2006) 1133-1143
62. Roth B.L., Craigo S.C., Choudhary M.S., Uluer A., Monsma F.J., Shen Y., Meltzer H.Y., and Sibley D.R. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. Journal of Pharmacology and Experimental Therapeutics 268 (1994) 1403-1410
63. Routledge C., Bromidge S.M., Moss S.F., Price G.W., Hirst W., Newman H., Riley G., Gager T., Stean T., Upton N., Clarke S.E., Brown A.M., and Middlemiss D.N. Characterization of SB-271046: A potent, selective and orally active 5-HT6 receptor antagonist. British Journal of Pharmacology 130 (2000) 1606-1612
64. Ruat M., Traiffort E., Arrang J.M., Tardivellacombe J., Diaz J., Leurs R., and Schwartz J.C. A novel rat serotonin (5-HT6) receptor-molecular cloning, localization and stimulation of cAMP accumulation. Biochemical and Biophysical Research Communications 193 (1993) 268-276
65. Russell M.G.N., and Dias R. Memories are made of this (perhaps): a review of serotonin 5-HT6 receptor ligands and their biological functions. Current Topics in Medicinal Chemistry 2 (2002) 643-654
66. Schechter L.E., Smith D.L., Zhang G.M., Li P., Lin Q., Lucki I., Rosenzweig-Lipson S., Robichaud A., Bernotas R., and Beyer C.E. WAY-466: In vitro and in vivo pharmacological characterization of a novel and selective 5-HT6 receptor agonist. Neuropsychopharmacology 29 (2004) S237
67. Schechter L.E., Lin Q., Smith D.L., Zhang G., Shan Q., Platt B., Brandt M.R., Dawson L.A., Cole D., Bernotas R., Robichaud A., Rosenzweig-Lipson S., and Beyer C.E. Neuropharmacological profile of novel and selective 5-HT(6) receptor agonists: WAY-181187 and WAY-208466. Neuropsychopharmacology 33 (2008) 1323-1335
68. Schreiber R., Sleight A.J., and Woolley M.L. 5-HT6 receptors as targets for the treatment of cognitive deficits in schizophrenia. In: Roth B.R. (Ed). Serotonin Receptors: From Molecular Pharmacology to Human Therapeutics (2006), Humana Press 495-515
69. Schreiber R., Vivian J., Hedley L., Szczepanski K., Secchi R.L., Zuzow M., van Laarhoven S., Moreau J.L., Martin J.R., Sik A., and Blokland A. Effects of the novel 5-HT6 receptor antagonist RO4368554 in rat models for cognition and sensorimotor gating. European Neuropsychopharmacology 17 (2007) 277-288
70. Setola V., and Roth B.L. Why mice are neither miniature humans nor small rats: A cautionary tale involving 5-hydroxytryptamine-6 serotonin receptor species variants. Molecular Pharmacology 64 (2003) 1277-1278
71. Shacham, S., Heal, D.J., Cheetham, S.C., Jackson, H.C., Mendelez, R., Rutkowski, J.V., Orbach, P., Gannon, K.S., 2006. PRX-07034, a potent and selective 5-HT6 receptor antagonist, reduces food intake and body weight in dietary-induced obese (DIO) rats. Society for Neuroscience Abstracts P62.10.
72. Sleight A.J., Monsma F.J., Borroni E., Austin R.H., and Bourson A. Effects of altered 5-ht(6) expression in the rat: Functional studies using antisense oligonucleotides. Behavioural Brain Research 73 (1996) 245-248
73. Stean T.O., Hirst W.D., Thomas D.R., Price G.W., Rogers D., Riley G., Bromidge S.M., Serafinowska H.T., Smith D.R., Bartlett S., Deeks N., Duxon M., and Upton N. Pharmacological profile of SB-357134: A potent, selective, brain penetrant, and orally active 5-HT6 receptor antagonist. Pharmacology Biochemistry and Behavior 71 (2002) 645-654
74. Stefulj J., Jernej B., Cicin-Sain L., Rinner I., and Schauenstein K. mRNA expression of serotonin receptors in cells of the immune tissues of the rat. Brain Behavior and Immunity 14 (2000) 219-224
75. Svenningsson P., Tzavara E.T., Qi H.S., Carruthers R., Witkin J.M., Nomikos G.G., and Greengard P. Biochemical and behavioral evidence for antidepressant-like effects of 5-HT6 receptor stimulation. Journal of Neuroscience 27 (2007) 4201-4209
76. Talpos J.C., Wilkinson L.S., and Robbins T.W. A comparison of multiple 5-HT receptors in two tasks measuring impulsivity. Journal of Psychopharmacology 20 (2006) 47-58
77. Ward R.P., and Dorsa D.M. Colocalization of serotonin receptor subtypes 5-HT2A, 5-HT2C, and 5-HT6 with neuropeptides in rat striatum. Journal of Comparative Neurology 370 (1996) 405-414
78. Wesolowska A., and Nikiforuk A. Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression. Neuropharmacology 52 (2007) 1274-1283
79. Woodward N.D., Purdon S.E., Meltzer H.Y., and Zald D.H. A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia. International Journal of Neuropsychopharmacology 8 (2005) 457-472
80. Woolley M.L., Bentley J.C., Sleight A.J., Marsden C.A., and Fone K.C.F. A role for 5-ht(6) receptors in retention of spatial learning in the Morris water maze. Neuropharmacology 41 (2001) 210-219
81. Woolley M.L., Marsden C.A., and Fone K.C.F. 5-HT6 receptors. Current Drug Targets-CNS and Neurological Diseases 3 (2004) 59-79
82. Woolley M.L., Marsden C.A., Sleight A.J., and Fone K.C.F. Reversal of a cholinergic-induced deficit in a rodent model of recognition memory by the selective 5-HT6 receptor antagonist, Ro 04-6790. Psychopharmacology 170 (2003) 358-367
83. Yang G.B., Qiu C.L., Zhao H., Liu Q., and Shao Y.M. Expression of mRNA for multiple serotonin (5-HT) receptor types/subtypes by the peripheral blood mononuclear cells of rhesus macaques. Journal of Neuroimmunology 178 (2006) 24-29
84. Yau J.L.W., Noble J., Widdowson J., and Seckl J.R. Impact of adrenalectomy on 5-HT6 and 5-HT7 receptor gene expression in the rat hippocampus. Molecular Brain Research 45 (1997) 182-186
85. Yoshioka M., Matsumoto M., Togashi H., Mori K., and Saito H. Central distribution and function of 5-HT6 receptor subtype in the rat brain. Life Sciences 62 (1998) 1473-1477
86. Yun H.M., Kim S., Kim H.J., Kostenis E., Kim J.I., Seong J.Y., Baik J.H., and Rhim H. The novel cellular mechanism of human 5-HT6 receptor through an interaction with Fyn. Journal of Biological Chemistry 282 (2007) 5496-5505